πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8597660

Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8580927

Engineered antibody constant domain molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8574853

Monoclonal antibodies that neutralize anthrax toxins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575375

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore m

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8568739

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8557844

Substrate reduction therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8557788

Prevention of tissue ischemia and related compositions

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8556882

Inducible interleukin-12

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8551936

Defensin-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546091

AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546524

Smoothened polypeptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8545888

Tendon stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536148

Disabling autophagy as a treatment for lysosomal storage diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8530167

Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524248

Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524239

Photosensitizing antibody-fluorophore conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518968

Hydrazone and diacyl hydrazine compounds and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518957

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing in

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, composition

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8506961

Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501912

Filipil compositions and methods for treating cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501688

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8481255

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470888

Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted